Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoclopramide for Anemia in MDS
NCT00120653Phase 2Withdrawn
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metoclopramide in myelodysplastic syndrome (MDS), sponsored by National Heart, Lung, and Blood Institute. Planned start Jul 2005; status: withdrawn.
02
Drugs
metoclopramide
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00120653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00120653.